Clarivate Plc: Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Plc (NYSE: CLVT) announced a cash tender offer to purchase up to $75M of its 3.875% Senior Secured Notes due 2028. The offer, managed by Citigroup, expires on September 23, 2026, with a settlement date of September 25, 2026. The total consideration is based on a fixed spread and reference yield, with accrued interest also payable.

Original reporting
Published Sep 17, 2026, 12:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 1:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CLVT
Neutral
high confidence
Mentioned
$CLVT
Relevance
7/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$CLVTNeutralMed
01

Why it matters

The offer provides a clear deadline (Sept 23) for note holders and may influence the pricing of Clarivate's existing debt instruments.

02

Market read

Primary corporate action affecting Clarivate's capital structure; relevant for fixed‑income and equity traders.

03

What to watch

Potential impact of the offer on Clarivate's credit rating and future borrowing capacity.

Relevance 7/10Novelty 7/10Timing: today

Background

Clarivate Science Holdings Corp. is the wholly‑owned subsidiary executing the tender offer for its own senior secured notes.

Company-level read

Ticker impact

$CLVTNeutralHigh confidence
Context

Clarivate announced a cash tender offer to purchase up to $75 million of its 3.875% senior secured notes due 2028.

Expected impact

Potential modest upside to CLVT equity as the market views the buyback as a confidence signal, while note prices may tighten.

Evidence & confidence

First‑report disclosure of a sizable ($75 M) tender offer with defined expiration and pricing mechanics creates a clear trading decision point.

Market effects

May signal increased cash generation in the information services sector, prompting peers to consider similar debt‑management actions.

Limited to U.S. and European investors holding Clarivate notes; no broad regional effect.

Low global impact; primarily relevant to fixed‑income and equity investors in Clarivate.

Counterpoint

The tender offer could be a defensive move to shore up balance sheet amid uncertain demand, suggesting caution on equity.

Key entities

  • Clarivate Plc

    Issuer of the senior secured notes and sponsor of the tender offer.

  • Citigroup Global Markets Inc.

    Dealer manager for the tender offer.

Related articles

$CLVTHigh

CLARIVATE PLC (CLVT): Other Events

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary,

$CLVTMed

Clarivate Plc Q2 2026 Earnings Call Summary

Clarivate Plc (Q2 2026) discussed its Value Creation Plan to shift from transactional to recurring subscription revenue. It plans to divest the Life Sciences & Healthcare segment by year-end 2026, targeting about 92% recurring revenue pro forma. Management cited a $269m non-cash impairment, $70m one-time costs, and expects low-end FCF due to transaction and restructuring costs.

$CLVTMed

Clarivate Reports Second Quarter 2026 Results

Clarivate Plc (NYSE: CLVT) reported Q2 2026 results for the quarter ended June 30. Total revenue fell to $587.3 million from $621.4 million a year earlier, while organic revenues declined 1.5%. Net loss widened to $268.6 million due to a $221.7 million goodwill impairment; adjusted net income was $123.1 million. The company reaffirmed its 2026 outlook and cited a Life Sciences & Healthcare divestiture.

$CLVTMedAI 8/10

CLARIVATE PLC (CLVT): Results of Operations and Financial Condition

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Clarivate Reports Second Quarter 2026 Results — Delivers continued progress on strategic and financial priorities through Value Creation Plan — — Sharpens focus and enhances financial profile with previously announced Life Sciences & Healthcare segment divestiture — — Reaffirms